Evidence map›Paper›PMID 32997546›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Prediction of Heparin Induced Thrombocytopenia (HIT) Using a Combination of 4Ts Score and Screening Immune Assays.

Rajat Thawani, Srikant Nannapaneni, Vivek Kumar, Phone Oo, Michael Simon, Anna Huang, Ishan Malhotra, Yiqing Xu

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Anticoagulant Medications: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2024
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rajat ThawaniDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Srikant NannapaneniDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Vivek KumarDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Phone OoDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Michael SimonDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Anna HuangDepartment of Sociomedical Sciences, 33638Columbia University Mailman School of Public Health, New York, NY, USA.
Ishan MalhotraDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Yiqing XuDivision of Hematology/Oncology, Department of Medicine, 2042Maimonides Medical Center, Brooklyn, NY, USA.ORCID https://orcid.org/0000-0003-0034-9870
Maimonides Medical Center · USColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical assessment (4Ts) followed by testing for Heparin/platelet factor 4 (HPF4) antibody in intermediate and high risk patients is the standard algorithm of pretest for Heparin induced thrombocytopenia (HIT), and the diagnosis is confirmed by serotonin releasing assay (SRA) in those who have positive antibodies. We conducted a retrospective analysis in a cohort of patients treated in a community hospital who had HIT antibody test by either ELISA or a rapid Particle Immunofiltration Assay (PIFA), regardless of their 4Ts scores. Among 224 patients, 17 had HIT. The PPV for those with a 4 T score ≥4 was 10.4%, which misdianosed 3 patients with HIT who tested positive for antibodies. Combining 4 T score ≥4 AND positive HIT antibody showed a PPV of 20.3% and a sensitivity of 70.6%, misdiagnosing 5 HIT patients. Using 4Ts ≥4 OR positive HIT antibody showed 100% sensitivity and 100% negative predictive value (NPV). The ELISA test had 100% sensitivity and 100% NPV, while the PIFA test missed 2 HIT patients, with sensitivity of 60% and NPV of 96.7%. Our results suggest that SRA testing should be conducted if a patient presents with a 4 T score ≥4 OR a positive HIT antibody, and antibody tests should be conducted for every patient suspected of HIT.

Indexed as

AdultAgedAged, 80 and overFemaleHeparinHumansMaleMiddle AgedRetrospective StudiesThrombocytopeniaYoung AdultHeparin4Ts scorediagnosisdiagnostic testheparin-induced thrombocytopeniaheparin induced thrombocytopenia (HIT)immune assayprobabilityserotonin releasing assay (SRA)thrombocytopeniathrombosis

Identifiers

PMID32997546
PMCPMC7533921
OpenAlexW3090990347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.